These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32564869)

  • 41. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.
    Harper A; Blackwood L
    J Small Anim Pract; 2017 Apr; 58(4):227-230. PubMed ID: 28133740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of i.v. administered tirapazamine plus cyclophosphamide.
    Hoff PM; Saad ED; Ravandi-Kashani F; Czerny E; Pazdur R
    Anticancer Drugs; 2001 Jul; 12(6):499-503. PubMed ID: 11459995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer.
    Mitchell L; Thamm DH; Biller BJ
    J Vet Intern Med; 2012; 26(2):355-62. PubMed ID: 22303814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
    J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
    Toffoli G; Sorio R; Aita P; Crivellari D; Corona G; Bearz A; Robieux I; Colussi AM; Stocco F; Boiocchi M
    Clin Cancer Res; 2000 Jun; 6(6):2279-87. PubMed ID: 10873078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
    Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
    Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats.
    Hadden AG; Cotter SM; Rand W; Moore AS; Davis RM; Morrissey P
    J Vet Intern Med; 2008; 22(1):153-7. PubMed ID: 18289303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007-2012).
    Best MP; Fry DR
    J Am Vet Med Assoc; 2013 Oct; 243(7):1025-9. PubMed ID: 24050570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study.
    Richardson PG; Bringhen S; Voorhees P; Plesner T; Mellqvist UH; Reeves B; Paba-Prada C; Zubair H; Byrne C; Chauhan D; Anderson K; Nordström E; Harmenberg J; Palumbo A; Sonneveld P
    Lancet Haematol; 2020 May; 7(5):e395-e407. PubMed ID: 32213344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin-Madison protocol: 119 cases (2004-2012).
    Collette SA; Allstadt SD; Chon EM; Vernau W; Smith AN; Garrett LD; Choy K; Rebhun RB; Rodriguez CO; Skorupski KA
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1(Suppl 1):136-46. PubMed ID: 26109275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
    Wagner A; Hempel G; Boos J
    Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma.
    Teske E; van Lankveld AJ; Rutteman GR
    Vet Comp Oncol; 2014 Mar; 12(1):37-46. PubMed ID: 22489828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.
    Hammond LA; Eckardt JR; Baker SD; Eckhardt SG; Dugan M; Forral K; Reidenberg P; Statkevich P; Weiss GR; Rinaldi DA; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 1999 Aug; 17(8):2604-13. PubMed ID: 10561328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy of advanced mammary adenocarcinoma in 14 cats.
    Jeglum KA; deGuzman E; Young KM
    J Am Vet Med Assoc; 1985 Jul; 187(2):157-60. PubMed ID: 3897157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma.
    Zimmerman TM; Grinblatt DL; Malloy R; Williams SF
    Cancer; 1998 Oct; 83(8):1540-5. PubMed ID: 9781947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer.
    Scheithauer W; Kornek GV; Raderer M; Schüll B; Schmid K; Längle F; Huber H
    Ann Oncol; 2002 Oct; 13(10):1583-9. PubMed ID: 12377646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results of a phase II clinical trial on the use of ifosfamide for treatment of cats with vaccine-associated sarcomas.
    Rassnick KM; Rodriguez CO; Khanna C; Rosenberg MP; Kristal O; Chaffin K; Page RL
    Am J Vet Res; 2006 Mar; 67(3):517-23. PubMed ID: 16506920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide.
    Balzarotti M; Spina M; Sarina B; Magagnoli M; Castagna L; Milan I; Ripa C; Latteri F; Bernardi D; Bertuzzi A; Nozza A; Roncalli M; Morenghi E; Tirelli U; Santoro A
    Ann Oncol; 2002 Sep; 13(9):1341-6. PubMed ID: 12196358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
    Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
    J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics.
    Rischin D; Ackland SP; Smith J; Garg MB; Clarke S; Millward MJ; Toner GC; Zalcberg J
    Ann Oncol; 2002 Nov; 13(11):1810-8. PubMed ID: 12419756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.